Skip to main content
Equibles

Sam

Analyst

Mizuho

Equibles does not estimate personal net worth.

About Sam

Sam is recorded as Analyst at Mizuho. Sam has spoken on 1 investor event across 1 company, most recently for Verastem, Inc. on June 23, 2026. The companies whose calls Sam spoke on are classified in the Healthcare sector.

Sam on recent calls

“Maybe a little bit more color on the current strategy for the 1200 MIG, assuming it gets cleared. Any updates on what the clinical plan is forward for that dose?”
Analyst — Mizuho, Verastem Oncology VS-7375 TARGET-D Conference Call ·

Affiliation history

  • Mizuho

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity